Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe added to Statin in Post-ACS Patients
NCT00652717Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2005
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: LDL Cholesterol Levels at 42 days. Started Feb 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00652717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652717.